Safeguard Scientifics First Quarter 2011 Financial Results Recap
This morning, we announced our first quarter 2011 financial results and reported on the exciting progress achieved along three key facets of our strategic game…
Posted by
This morning, we announced our first quarter 2011 financial results and reported on the exciting progress achieved along three key facets of our strategic game…
Posted by
This morning, we announced our fourth quarter and year-end 2010 financial results. In 2010, our aggregate partner company revenue was $403 million, up 54 percent…
Posted by
Last year around this time, as we headed into 2010 and were making plans for the coming year, we were in the midst of the…
Posted by
Cash on our balance sheet may be growing with every well-timed exit transaction and positive momentum is driving Safeguard’s stock price upward; however, our IR…
Posted by
Earlier this quarter, we announced that partner companies Clarient (Nasdaq: CLRT) and Avid Radiopharmaceuticals had signed definitive agreements to be acquired by GE Healthcare and…
Posted by
Earlier today in our third quarter results conference call, we announced that our aggregate partner company revenue increased 73 percent in Q3, and that for…
Posted by
At Safeguard Scientifics, our strategy is to provide growth capital for entrepreneurial and innovative life sciences and technology companies, build value in those companies and…
Posted by
On Tuesday, Oct. 5, Safeguard Scientifics will be hosting Investor Day 2010 from 8 a.m. to 11:30 a.m. EDT at The Yale Club of New…
Posted by
In our report for the period ended Dec. 31, 2009 that was released this morning, we updated investors on the significant progress achieved by Safeguard…
Posted by